Venous thrombosis in afibrinogenemia: a successful use of rivaroxaban
2015; Wiley; Volume: 21; Issue: 5 Linguagem: Inglês
10.1111/hae.12734
ISSN1365-2516
AutoresMaurizio Margaglione, Gennaro Vecchione, Filomena Cappucci, Luca Macarini, Giovanna D’Andrea, C. Di Matteo, Elvira Grandone,
Tópico(s)Acute Myocardial Infarction Research
ResumoHaemophiliaVolume 21, Issue 5 p. e431-e433 Letter to the Editor Venous thrombosis in afibrinogenemia: a successful use of rivaroxaban M. Margaglione, Corresponding Author M. Margaglione Medical Genetics, Department of Clinical and Experimental Medicine, University of Foggia, Foggia, Italy Correspondence: Maurizio Margaglione, Medical Genetics, Department of Clinical and Experimental Medicine, University of Foggia, viale Pinto, Foggia 71100, Italy. Tel.: +39 0881 733842; fax: +39 0881 736082; e-mail: [email protected]Search for more papers by this authorG. Vecchione, G. Vecchione Atherosclerosis and Thrombosis Unit, I.R.C.C.S. "Casa Sollievo della Sofferenza", San Giovanni Rotondo, ItalySearch for more papers by this authorF. Cappucci, F. Cappucci Atherosclerosis and Thrombosis Unit, I.R.C.C.S. "Casa Sollievo della Sofferenza", San Giovanni Rotondo, ItalySearch for more papers by this authorL. Macarini, L. Macarini Department of Medical and Surgical Sciences, University of Foggia, Foggia, ItalySearch for more papers by this authorG. D'Andrea, G. D'Andrea Medical Genetics, Department of Clinical and Experimental Medicine, University of Foggia, Foggia, ItalySearch for more papers by this authorC. Di Matteo, C. Di Matteo Medical Genetics, Department of Clinical and Experimental Medicine, University of Foggia, Foggia, ItalySearch for more papers by this authorE. Grandone, E. Grandone Atherosclerosis and Thrombosis Unit, I.R.C.C.S. "Casa Sollievo della Sofferenza", San Giovanni Rotondo, ItalySearch for more papers by this author M. Margaglione, Corresponding Author M. Margaglione Medical Genetics, Department of Clinical and Experimental Medicine, University of Foggia, Foggia, Italy Correspondence: Maurizio Margaglione, Medical Genetics, Department of Clinical and Experimental Medicine, University of Foggia, viale Pinto, Foggia 71100, Italy. Tel.: +39 0881 733842; fax: +39 0881 736082; e-mail: [email protected]Search for more papers by this authorG. Vecchione, G. Vecchione Atherosclerosis and Thrombosis Unit, I.R.C.C.S. "Casa Sollievo della Sofferenza", San Giovanni Rotondo, ItalySearch for more papers by this authorF. Cappucci, F. Cappucci Atherosclerosis and Thrombosis Unit, I.R.C.C.S. "Casa Sollievo della Sofferenza", San Giovanni Rotondo, ItalySearch for more papers by this authorL. Macarini, L. Macarini Department of Medical and Surgical Sciences, University of Foggia, Foggia, ItalySearch for more papers by this authorG. D'Andrea, G. D'Andrea Medical Genetics, Department of Clinical and Experimental Medicine, University of Foggia, Foggia, ItalySearch for more papers by this authorC. Di Matteo, C. Di Matteo Medical Genetics, Department of Clinical and Experimental Medicine, University of Foggia, Foggia, ItalySearch for more papers by this authorE. Grandone, E. Grandone Atherosclerosis and Thrombosis Unit, I.R.C.C.S. "Casa Sollievo della Sofferenza", San Giovanni Rotondo, ItalySearch for more papers by this author First published: 02 June 2015 https://doi.org/10.1111/hae.12734Citations: 10Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1de Moerloose P, Casini A, Neerman-Arbez M. Congenital fibrinogen disorders: an update. Semin Thromb Hemost 2013; 39: 585–95. 10.1055/s-0033-1349222 CASPubMedWeb of Science®Google Scholar 2Lak M, Keihani M, Elahi F, Peyvandi F, Mannucci PM. Bleeding and thrombosis in 55 patients with inherited afibrinogenaemia. Br J Haematol 1999; 107: 204–6. 10.1046/j.1365-2141.1999.01681.x CASPubMedWeb of Science®Google Scholar 3Girolami A, Ruzzon E, Tezza F, Scandellari R, Vettore S, Girolami B. Arterial and venous thrombosis in rare congenital bleeding disorders: a critical review. Haemophilia 2006; 12: 345–51. 10.1111/j.1365-2516.2006.01299.x CASPubMedWeb of Science®Google Scholar 4Schuepbach RA, Meili EO, Schneider E, Peter U, Bachli EB. Lepirudin therapy for thrombotic complications in congenital afibrinogenaemia. Thromb Haemost 2004; 91: 1044–6. CASPubMedWeb of Science®Google Scholar 5Santacroce R, Cappucci F, Pisanelli D et al. Inherited abnormalities of fibrinogen: 10-year clinical experience of an Italian group. Blood Coagul Fibrinol 2006; 17: 235–40. 10.1097/01.mbc.0000224841.48463.be CASPubMedWeb of Science®Google Scholar 6Mueck W, Stampfuss J, Kubitza D, Becka M. Clinical pharmacokinetic and pharmacodynamic profile of rivaroxaban. Clin Pharmacokinet 2014; 53: 1–16. 10.1007/s40262-013-0100-7 CASPubMedWeb of Science®Google Scholar 7Rohde G. Determination of rivaroxaban - a novel, oral, direct Factor Xa inhibitor - in human plasma by high-performance liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2008; 872: 43–50. 10.1016/j.jchromb.2008.07.015 CASPubMedWeb of Science®Google Scholar 8Grandone E, Tiscia G, Cappucci F et al. Clinical histories and molecular characterization of two afibrinogenemic patients: insights into clinical management. Haemophilia 2012; 18: e16–8. 10.1111/j.1365-2516.2011.02656.x CASPubMedWeb of Science®Google Scholar 9Bornikova L, Peyvandi F, Allen G, Bernstein J, Manco-Johnson MJ. Fibrinogen replacement therapy for congenital fibrinogen deficiency. J Thromb Haemost 2011; 9: 1687–704. 10.1111/j.1538-7836.2011.04424.x CASPubMedWeb of Science®Google Scholar Citing Literature Volume21, Issue5September 2015Pages e431-e433 ReferencesRelatedInformation
Referência(s)